Hepatitis C Virus Genotypes in the United States: Epidemiology, Pathogenicity, and Response to Interferon Therapy

Annals of Internal Medicine

Volumn 125, Issue 8, 1996, Pages 634-639

  Zein, Nizar N ^b   Rakela, Jorge ^a   Krawitt, Edward L ^c   Reddy, K Rajender ^d   Tominaga, Tomonari ^b   Persing, David H ^b  

^a Division of Transplantation   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; PRIMER DNA;

ADULT; ARTICLE; CLASSIFICATION; FEMALE; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOGENICITY; RETROSPECTIVE STUDY; UNITED STATES; VIROLOGY;

ADULT; ANTIVIRAL AGENTS; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERONS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 0030587906     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-8-199610150-00002     Document Type: Article

References (31)

1. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989;321:1494-500.
2. Di Bisceglie AM, Goodman ZD, Ishak KC, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology. 1991;14:969-74.
3. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A. 1991;15:2451-5.
4. Zein NN, Rakela J, Persing DH. Genotype-dependent serologic reactivities in patients infected with chronic hepatitis C virus in the United States. Mayo Clin Proc. 1996;70:449-52.
5. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med. 1995;122:161-8.
6. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M. et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology. 1992;16:293-9.
7. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993;74: 2391-9.
8. Houghton M, Weiner AJ, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 1991;14:381-8.
9. Delisse AM, Descurieux M, Rutgers T, D'Hondt E, De Wilde M, Arima T, et al. Sequence analysis of the putative structural genes of hepatitis C virus from Japanese and European origin. J Hepatol. 1991;13(Suppl 4):S20-3.
10. Li JS, Tong SP, Vitvitski L, Lepot D, Trepo C. Two French genotypes of hepatitis C virus: homology of the predominant genotype with the prototype American strain. Gene. 1991;105:167-72.
11. Li JS, Tong SP, Vitvitski L, Lepot D, Trepo C. Evidence of two major genotypes of hepatitis C virus in France and close relatedness of the predominant one with the prototype virus. J Hepatol. 1991;13(Suppl 4):S33-7.
12. Chen PJ, Lin MH, Tai KF, Liu PC, Lin CI, Chen DS. The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5′ termini of viral genomic and antigenomic RNA. Virology. 1992;188:102-13.
13. Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun. 1990;170:1021-5.
14. Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Mori S, Hijikata M, et al. Distribution of plural HCV types in Japan. Biochem Biophys Res Commun. 1991;181:279-85.
15. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimotohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun. 1991;175:220-8
16. Han JH, Shyamala V, Richman KH, Brauer MJ, Irvine B, Urdea MS, et al. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end. Proc Natl Acad Sci U S A. 1991;88:1711-5.
17. Okamoto H, Kurai K, Okada S, Yamamoto K, Lizuka H, Tanaka T, et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology. 1992;188:331-41.
18. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 1992;73:673-9.
19. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, et al. Hepatitis C genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology. 1994;19:13-8.
20. Pol S, Thiers V, Nousbaum JB, Legendre C, Berthelot P, Kreis H, et al. The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology. 1995;108: 581-3.
21. Pozzato G, Moretti M, Franzin F, Croce LS, Tiribelli C, Masayu T, et al. Severity of liver disease with different hepatitis C viral clones [Letter]. Lancet. 1991;338:509.
22. Zein NN, Rakela J, Poterucha JJ, Steers JL, Wiesner RH, Persing DH. Hepatitis C genotypes in liver transplant recipients: distribution and one year follow-up. Journal of Liver Transplantation and Surgery. 1995;6:354-7.
23. Gordon FD, Zein NN, Poterucha JJ, Gross JB, Gossard AA, Steers JL, et al. Hepatitis C genotype 1b in liver transplant recipients is associated with an increased incidence and severity of recurrence [Abstract]. Gastroenterology. 1995;108:A1074.
24. Zein NN, Gross JB Jr, Poterucha JJ, Gossard AA, Persing DH. Significance of HCV RNA level and relationship to viral genotype in patients with hepatitis C [Abstract]. Gastroenterology. 1995;108:A1208.
25. Zein NN, Rakela J. Interferon therapy in hepatitis C. Semin Gastrointest Dis. 1995;1:46-53.
26. Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ouzan D, et al. Comparision of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology. 1991;101:497-502.
27. Karino Y, Matsushima T, Saga A, Tsuyuguchi M, Miyazaki T, Toyota J. Treatment of chronic non-A, non-B hepatitis with interferon. Gastroenterol Jpn. 1991;26(Suppl 3):234-8.
28. Weiland O, Zhang YY, Widell A. Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment. Scand J Infect Dis. 1993;25:25-30.
29. Lin R, Schoeman MN, Craig PI, Bilous M, Grierson J, McDonald JA, et al. Can the response to interferon treatment be predicted in patients with chronic active hepatitis C? Aust N Z J Med. 1991;21:387-92.
30. Chayama K, Tsubota A, Arase Y, Saitoh S, Ikeda K, Matsumoto T, et al. Effect of lymphoblastoid alfa-interferon in patients with chronic hepatitis C having different genotypic subtype of hepatitis C virus. Gastroenterol Jpn. 1993;28(Suppl 5):45-7.
31. Takada N, Takase S, Takada A. Effects of genotypes of hepatitis C virus on interferon treatment for chronic type C hepatitis. Gastroenterol Jpn. 1993;28: 268-75.